Lamivudine plus indinavir/ritonavir maintenance therapy does not appear to stabilise disease progression

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1569, 2007-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimum doses for regimens of indinavir + ritonavir in HIV

Inpharma, Vol. 1, Iss. 1470, 2005-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Indinavir therapy may be optimised by using reduced doses (400mg or 600mg, twice daily), in combination with low-dose ritonavir

Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Amprenavir/lamivudine/ritonavir/stavudine: Graves' disease (first report with amprenavir) leading to hyperthyroidism: case report

Reactions Weekly, Vol. 1, Iss. 1109, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

HIV-1 immunogen does not appear to improve HIV progression-free survival

Inpharma, Vol. 1, Iss. 1263, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Dual protease inhibitor (PI) therapy and the inclusion of ritonavir do not appear to increase the incidence of hepatotoxicity

Inpharma, Vol. 1, Iss. 1340, 2002-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite